The larger bets should still fall on the common gap as there was no news to push the price up for a sustained period. Also the price is currently roughly at the level of mid to late 2007, when it couldn't push above $0.16, so there is naturally strong resistance at this level.

Technically there was a breakout, but without supporting news, the follow up move might not occur. Speculating on more material events that could have caused this explosive price movement some people refer to the company's upcoming participation in the BTI Life Sciences 2nd Annual Congress and Expo of Molecular Diagnostics. The scientific meeting will be held in Beijing during November 19-21.

This is a chance for Power3 to demonstrate their disease diagnostic products that are being developed and maybe get some acknowledgement which would eventually lead to easier fund raising.

Stock price seem to just hit and run on the news, as Mondays advance has corrected on Tuesday. The company has been playing with Green Valley project for nearly three year so minor developments no longer affect the share price for long.

The more interesting development was management's recent decision to move their company up a step and get on the OTCBB. The idea was introduced last Friday. Combined with the company's intentions to build bio-diesel production plant in Georgia, this announcement has clearly added to the overall investors' optimism.

We know the company will be financed by the state of Georgia and get nearly $33 million to build their plant. And with them becoming a reporting entity we will get to see how the money is spent. From what the management is saying, both their projects are rather sound. If we will see numbers in financial reports supporting the possibility of these projects actually being complete it would make the price tenfold of its current value in no time.

However until then we have to take management's words for granted so caution must be applied. Putting the stock on a watchlist is probably the best thing to do right now.

HTDS announced their subsidiary, Mellow Hope, has acquired the necessary certificate to start selling swine flu vaccines in Chile. The first shipments are expected to be seen in a time of couple weeks. Management has also stated this is the first H1N1 Influenza A vaccine in Chile to be sold by a foreign company.

For sales in Chile, the certificate guaranties advantage against possible foreign competitors but grants no benefit in competing against domestic companies. The company will still have to overcome the usual market entry barriers and gradually work their way to gaining some share.

Further, we're still waiting for the management to post numbers on initial vaccine order. Promised to be a significant amount it might push the stock somewhat up, but the continuity of significant revenues from this is currently still questionable.

The thing is, the company might be too late to jump the train altogether. Despite Chile considered one of the South American countries most affected by the disease, the pandemic was already partly controlled back in July 2009 when the rate of infections was reported to fall.

The product still has to gain popularity amongst consumers, but calculations provided by CEO look ambitious. If the product is sold at all 4,000 stores (which already have the product at shelves) at a rate of 1 bottle per day, that would bring in $6 million per quarter. Of course, this "modest" calculation is already too optimistic, but it shows the potential.

Still, without actual sales, the CEO can talk all he wants but this won't interest investors. This stock is currently a gamble. The product might be worth something, but overwhelmed by cheaper competitors solution and the company will have to invest in marketing before thinking about serious sales.

Since there's limited data on their financials (being on pinksheets and all), we cannot expect them to have a hundred million worth bank account. In other words till we see sheets of numbers supporting the company's business model, the stock isn't going to blossom.

The Popular Science magazine has added Eco2's technology to the list of the year's top 100 innovations. That was more than enough to push up their stock price which has already been trying to break up.

Their stock soared on Friday and many investors are likely to pay more attention to the company in the future. This acknowledgement also might open Eco2 a way to receive so needed funding from sources like private capital, that were previously unavailable.

The lack of funding and the need for a new plant are the most troubling aspects of Eco2. The company expects to get operational in the second quarter of 2010, when they build a new plant that's able of faster and larger capacity recycling.

With only acknowledgement they won't be able to make a fortune, but the company is likely to receive some financial support from the side or even merger/acquisition offers. But those are just speculation at the moment, though the stock price is likely to appreciate quite a bit, which was already seen during Friday's trading.

First of all, let's see what the fundamentals have to tell. The reported $13.3 million loss was caused by one time items (charges related to the sale of M/V Richmon dry bulk carrier and interest rate swaps) without which the company would have seen a net income of $9.5 million or 11 cents per share. That was slightly above the year ago result of $8.9 million so we can see at least mild improvement.

The downside is that the company still lost money and it will affect their working capital. The gain, excluding special items, wasn't much larger than a year ago and stock price move on announcement reacted to the fact it has beaten analyst estimates.

But even with downsides, the company is not in bad position capital vise and so their stock might be considered under priced at the moment. The short term uptrend is already forming and currently there are no strong reversal signals in place. Even though this stock isn't likely to become an explosive gainer, we must consider OceanFreight has some future prospects.

The company's CEO has stated in the press release: "we have secured gross revenues of $115 million until the end of 2010 with 92% fleet charter coverage for the remainder of 2009 and 72% for 2010." This alone shows they're definitely not going out of business and even have assured revenue for over a year. Moreover their current P/S ration is already lower than industry's average, which suggests stock price growth should follow.